These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16036095)

  • 1. Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
    Miller PD
    Curr Osteoporos Rep; 2005 Mar; 3(1):5-12. PubMed ID: 16036095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists.
    Miller PD
    Curr Rheumatol Rep; 2005 Mar; 7(1):53-60. PubMed ID: 15760581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for bisphosphonates in chronic kidney disease?
    Miller PD
    Semin Dial; 2007; 20(3):186-90. PubMed ID: 17555478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney and bisphosphonates.
    Miller PD
    Bone; 2011 Jul; 49(1):77-81. PubMed ID: 21232648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of osteoporosis in chronic renal disease.
    Miller PD
    Semin Nephrol; 2009 Mar; 29(2):144-55. PubMed ID: 19371805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease and bone fracture: a growing concern.
    Nickolas TL; Leonard MB; Shane E
    Kidney Int; 2008 Sep; 74(6):721-31. PubMed ID: 18563052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteoporosis in renal insufficiency.
    Schipper LG; Fleuren HW; van den Bergh JP; Meinardi JR; Veldman BA; Kramers C
    Clin Rheumatol; 2015 Aug; 34(8):1341-5. PubMed ID: 25630310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary osteoporosis UPDATE. Therapy for bone-mineral disease in CKD-5D patients].
    Orita H; Yoshimoto W; Tanaka Y; Yamanaka S; Shigematsu T
    Clin Calcium; 2010 May; 20(5):752-7. PubMed ID: 20445287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of bisphosphonates in chronic kidney disease].
    Torregrosa JV; Ramos AM
    Nefrologia; 2010; 30(3):288-96. PubMed ID: 20514097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
    Okuno S; Ishimura E
    Clin Calcium; 2010 May; 20(5):655-62. PubMed ID: 20445276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis in patients with chronic renal failure : evaluation and management ? Role of bone biopsy].
    Chatzipetrou V; Gerbaix M; Ferrari S; Trombetti A
    Rev Med Suisse; 2018 Nov; 14(626):2012-2017. PubMed ID: 30422421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and chronic kidney disease.
    Stehman-Breen C
    Semin Nephrol; 2004 Jan; 24(1):78-81. PubMed ID: 14730513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
    Courtney AE; Maxwell AP
    Postgrad Med J; 2009 Jun; 85(1004):327-30. PubMed ID: 19528309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease-chronic kidney disease-mineral and bone disorder: osteoporosis.
    Lee WL; Cheng MH; Tarng DC; Yang WC; Lee FK; Wang PH
    J Chin Med Assoc; 2013 Jul; 76(7):365-71. PubMed ID: 23664736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
    Imanishi Y
    Clin Calcium; 2012 Jul; 22(7):1025-33. PubMed ID: 22750935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bone biopsy in patients with chronic renal failure.
    Miller PD
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S140-50. PubMed ID: 18988699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.